Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LOSARTAN vs LOTEPREDNOL ETABONATE\TOBRAMYCIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LOSARTAN vs LOTEPREDNOL ETABONATE\TOBRAMYCIN: Safety Overview

Metric LOSARTAN LOTEPREDNOL ETABONATE\TOBRAMYCIN
Total FAERS Reports 21,916 136
Deaths Reported 2,034 0
Death Rate 9.3% N/A
Hospitalizations 7,032 1
Average Patient Age 65.2 yrs 57.3 yrs
% Female Patients 59.8% 81.5%
FDA Approval Date Apr 14, 1995 N/A
Manufacturer Aphena Pharma Solutions - Tennessee, LLC N/A
Route ORAL N/A
Marketing Status Prescription N/A